Further reading and references Wilding et al: Once-Weekly Semaglutide in Adults with Overweight or Obesity Moiz et al: Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes Rubino et al: Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial Bolek et al: Effect of semaglutide with metformin for weight loss and fertility in polycystic ovary syndrome (PCOS) patients with obesity About the authorView full bio Dr Nienke Lees Women's Health Service Lead MB BChir, MA, MRCS(ENT), DOHNS, MRCGP, LMCA Dr Nienke Lees is the Women's Health Service Lead at Genwell
Spot the Difference: Like a lot of counterfeits, it can be very difficult to see the differences initially but when you look closer, there are a few differences between the structure, mechanism and packaging of the fake Ozempic
10.1080/07853890.2024.2337871 50 LiangY.ZhangC.WeiH.DuH.ZhangG.YangY.et al (2022)
A loss of 0.5-2 pounds per week is a healthy and sustainable rate
Publikation Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes, Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagstrm
Emerging Research Areas Chronobiology and Metabolic Peptides: Scientists are increasingly investigating how circadian rhythms interact with NNMT inhibition